These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 3311572

  • 1. Ciprofloxacin and norfloxacin, two fluoroquinolone antimicrobials.
    Nix DE, DeVito JM.
    Clin Pharm; 1987 Feb; 6(2):105-17. PubMed ID: 3311572
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Enoxacin: a new fluoroquinolone.
    Jaber LA, Bailey EM, Rybak MJ.
    Clin Pharm; 1989 Feb; 8(2):97-107. PubMed ID: 2645085
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Norfloxacin: a broad-spectrum quinolone for superficial eye infections].
    Grosset J.
    Pathol Biol (Paris); 1990 Sep; 38(7):735-41. PubMed ID: 2235090
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society.
    Louie TJ.
    CMAJ; 1994 Mar 01; 150(5):669-76. PubMed ID: 8313286
    [Abstract] [Full Text] [Related]

  • 9. Quinolone therapy in intensive care unit settings.
    Beam TR.
    New Horiz; 1993 May 01; 1(2):187-93. PubMed ID: 7922402
    [Abstract] [Full Text] [Related]

  • 10. Focus on oral ciprofloxacin; clinical and economic considerations.
    Pastel D.
    Hosp Pharm; 1989 Oct 01; 24(10):814-20, 823-6, 842. PubMed ID: 10295899
    [Abstract] [Full Text] [Related]

  • 11. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR, Sader HS, Stilwell MG, Dowzicky MJ, Jones RN.
    Diagn Microbiol Infect Dis; 2005 Jul 01; 52(3):187-93. PubMed ID: 16105563
    [Abstract] [Full Text] [Related]

  • 12. The fluoroquinolones for urinary tract infections: a review.
    Cunha BA.
    Adv Ther; 1994 Jul 01; 11(6):277-96. PubMed ID: 10150268
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Norfloxacin: a new targeted fluoroquinolone antimicrobial agent.
    Wolfson JS, Hooper DC.
    Ann Intern Med; 1988 Feb 01; 108(2):238-51. PubMed ID: 3277508
    [Abstract] [Full Text] [Related]

  • 15. Overview of the fluoroquinolone antibiotics.
    Just PM.
    Pharmacotherapy; 1993 Feb 01; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Overview of preclinical studies with ciprofloxacin.
    Sanders CC, Sanders WE, Goering RV.
    Am J Med; 1987 Apr 27; 82(4A):2-11. PubMed ID: 3646829
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Norfloxacin versus nalidixic acid in the treatment of urinary tract infections.
    Karachalios GN, Georgiopoulos AN.
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun 27; 25(6):317-9. PubMed ID: 3623736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.